• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期甲状腺乳头状癌的临床病理及预后特征综合分析

Comprehensive analysis of clinicopathologic and prognostic features in locally advanced thyroid papillary cancer.

作者信息

Jiwang Liang, Dongman Ye, Fengqin Fang, Yuejiao Zhao

机构信息

Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Department of Head and Neck Surgery, Liaoning Province, China.

Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Department of Medical Imaging, Liaoning Province, China.

出版信息

Braz J Otorhinolaryngol. 2025 Mar-Apr;91(2):101553. doi: 10.1016/j.bjorl.2024.101553. Epub 2025 Jan 3.

DOI:10.1016/j.bjorl.2024.101553
PMID:39753045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11753965/
Abstract

OBJECTIVE

Differentiated thyroid cancers tend to excellent long-term survival after surgery. However, Locally Advanced Papillary Thyroid Cancers (LAPTCs) have poor prognosis. This study was to investigate the clinicopathologic features of LAPTC and the risk factors that affect its postoperative recurrence. We aimed to construct a nomogram to predict Recurrence-Free Survival (RFS) in LAPTC.

METHODS

We retrospectively reviewed the data of patients who underwent surgery from 2011 to 2020 at a single institution. Univariate and multivariate analyses were used to investigate the clinicopathologic features of LAPTC. The risk factors that affecting recurrence of LAPTC were screened. The risk factors were subsequently integrated to establish a predictive model. C-index, receiver operating characteristic curve and calibration curve were used to validate the accuracy. A Decision Analysis Curve (DCA) was used to evaluate the clinical value.

RESULTS

A total of 2530 Early Papillary Thyroid Cancer (EPTC) and 764 LAPTC were enrolled. Compared to EPTC, the proportion of male, bilaterality, multifocality, tumor size > 1 cm, ETE, central lymph node metastasis, and lateral lymph node metastasis was higher in LAPTC (all p < 0.05). Univariate and multivariate analyses found that age ≥ 55-years-old, male, and ETE were independent risk factors for the LAPTC patients' RFS (all p < 0.05). C-index of the nomogram was 0.79. The AUC values of nomogram were 0.767 (95% CI 0.626‒0.909) and 0.798 (95% CI 0.669‒0.926) for 3- and 5-year RFS, respectively. The calibration curves of the nomogram showed good accuracy and consistency, and the DCA curves exhibited that the model had good clinical utility.

CONCLUSION

Male patients who with tumors tumor > 1 cm, bilaterality, multifocality, and ETE are more likely to become LAPTC. LAPTC patients with age ≥ 55-years-old, tumor size > 1 cm, and ETE are more likely to have postoperative recurrence. The model can help surgeons to predict 3- and 5-year RFS in LAPTC.

EVIDENCE LEVEL

This article's evidence level is four. Level 4 evidence, the case series, comes in the form of a group of patients subjected to surgical procedure. Authors may detect a statistically significant and clinically relevant outcome.

摘要

目的

分化型甲状腺癌术后长期生存率往往较好。然而,局部晚期甲状腺乳头状癌(LAPTC)预后较差。本研究旨在探讨LAPTC的临床病理特征及影响其术后复发的危险因素。我们旨在构建一个列线图来预测LAPTC的无复发生存期(RFS)。

方法

我们回顾性分析了2011年至2020年在单一机构接受手术的患者数据。采用单因素和多因素分析来研究LAPTC的临床病理特征。筛选出影响LAPTC复发的危险因素。随后将这些危险因素整合以建立一个预测模型。使用C指数、受试者工作特征曲线和校准曲线来验证准确性。采用决策分析曲线(DCA)来评估临床价值。

结果

共纳入2530例早期甲状腺乳头状癌(EPTC)和764例LAPTC。与EPTC相比,LAPTC中男性、双侧性、多灶性、肿瘤大小>1cm、甲状腺外侵犯(ETE)、中央淋巴结转移和侧方淋巴结转移的比例更高(均p<0.05)。单因素和多因素分析发现,年龄≥55岁、男性和ETE是LAPTC患者RFS的独立危险因素(均p<0.05)。列线图的C指数为0.79。列线图预测3年和5年RFS的AUC值分别为0.767(95%CI 0.626‒0.909)和0.798(95%CI 0.669‒0.926)。列线图的校准曲线显示出良好的准确性和一致性,DCA曲线表明该模型具有良好的临床实用性。

结论

肿瘤>1cm、双侧性、多灶性且有ETE的男性患者更易成为LAPTC。年龄≥55岁、肿瘤大小>1cm且有ETE的LAPTC患者术后更易复发。该模型可帮助外科医生预测LAPTC的3年和5年RFS。

证据水平

本文的证据水平为四级。四级证据,病例系列,以一组接受手术的患者为形式。作者可能检测到具有统计学意义和临床相关性的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/d43481d0fe1a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/58eef1f7e6df/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/5b4360bf3ab1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/f29da60e63c2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/7781ed5c4e35/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/d43481d0fe1a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/58eef1f7e6df/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/5b4360bf3ab1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/f29da60e63c2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/7781ed5c4e35/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3605/11753965/d43481d0fe1a/gr5.jpg

相似文献

1
Comprehensive analysis of clinicopathologic and prognostic features in locally advanced thyroid papillary cancer.局部晚期甲状腺乳头状癌的临床病理及预后特征综合分析
Braz J Otorhinolaryngol. 2025 Mar-Apr;91(2):101553. doi: 10.1016/j.bjorl.2024.101553. Epub 2025 Jan 3.
2
Risk factor analysis and prediction model construction for contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma : Sex, extrathyroidal tumor extension (ETE), tumor diameter and ipsilateral central lymph node metastasis (ICLNM) are risk factor for unilateral papillary thyroid carcinoma (UPTC): a case control study.单侧乳头状甲状腺癌(UPTC)的危险因素分析及对侧中央区淋巴结转移预测模型的建立:性别、甲状腺外肿瘤侵犯(ETE)、肿瘤直径和同侧中央区淋巴结转移(ICLNM)是单侧乳头状甲状腺癌(UPTC)的危险因素:一项病例对照研究。
World J Surg Oncol. 2024 Oct 25;22(1):280. doi: 10.1186/s12957-024-03565-5.
3
Comprehensive analysis of clinicopathologic and sonographic features in thyroid cancer with skip lymph node metastasis: establish and assessment of a prediction nomogram.甲状腺癌跳跃性淋巴结转移的临床病理及超声特征综合分析:预测列线图的建立与评估。
Braz J Otorhinolaryngol. 2023 Sep-Oct;89(5):101301. doi: 10.1016/j.bjorl.2023.101301. Epub 2023 Aug 3.
4
Significance of multifocality in papillary thyroid carcinoma.多灶性在甲状腺乳头状癌中的意义。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
5
Nomogram for predicting the risk of cervical lymph node metastases and recurrence in papillary thyroid carcinoma based on the thyroid differentiation score system and clinical characteristics.基于甲状腺分化评分系统和临床特征预测甲状腺乳头状癌颈部淋巴结转移及复发风险的列线图
BMC Endocr Disord. 2025 Feb 13;25(1):39. doi: 10.1186/s12902-025-01867-7.
6
Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning.基于超声的列线图,使用机器学习预测甲状腺乳头状癌的复发。
BMC Cancer. 2024 Jul 7;24(1):810. doi: 10.1186/s12885-024-12546-6.
7
Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma.预后营养指数预测甲状腺乳头状癌的侧颈部淋巴结转移和无复发生存。
BMC Cancer. 2024 Aug 22;24(1):1039. doi: 10.1186/s12885-024-12801-w.
8
Construction and validation of novel nomograms based on the log odds of positive lymph nodes to predict the prognosis of papillary thyroid cancer: a retrospective cohort study.基于阳性淋巴结对数优势比构建和验证新型列线图以预测甲状腺乳头状癌的预后:一项回顾性队列研究
Front Endocrinol (Lausanne). 2025 Mar 7;16:1411426. doi: 10.3389/fendo.2025.1411426. eCollection 2025.
9
Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.基于术前血清甲状腺球蛋白和甲状腺乳头状癌临床特征的列线图模型预测颈部淋巴结转移。
Front Endocrinol (Lausanne). 2022 Jul 15;13:937049. doi: 10.3389/fendo.2022.937049. eCollection 2022.
10
Predicting central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis: a preoperative study.预测合并桥本甲状腺炎的乳头状甲状腺癌中央淋巴结转移:一项术前研究
BMC Cancer. 2025 Mar 10;25(1):425. doi: 10.1186/s12885-025-13805-w.

本文引用的文献

1
Comprehensive analysis of clinicopathologic and sonographic features in thyroid cancer with skip lymph node metastasis: establish and assessment of a prediction nomogram.甲状腺癌跳跃性淋巴结转移的临床病理及超声特征综合分析:预测列线图的建立与评估。
Braz J Otorhinolaryngol. 2023 Sep-Oct;89(5):101301. doi: 10.1016/j.bjorl.2023.101301. Epub 2023 Aug 3.
2
Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?甲状腺分化癌的肿瘤总直径、多灶性、肿瘤灶数量或单侧性能否预测淋巴结转移或复发?
Endokrynol Pol. 2023;74(2):153-167. doi: 10.5603/EP.a2023.0015. Epub 2023 Apr 11.
3
Genetic analysis and clinicopathologic features of locally advanced papillary thyroid cancers: a prospective observational study.
局部晚期甲状腺乳头状癌的遗传分析及临床病理特征:一项前瞻性观察性研究。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6303-6313. doi: 10.1007/s00432-022-04541-w. Epub 2023 Feb 3.
4
Recurrence Factors and Characteristic Trends of Papillary Thyroid Cancer over Three Decades.三十年期间甲状腺乳头状癌的复发因素及特征性趋势
Int J Endocrinol. 2021 May 10;2021:9989757. doi: 10.1155/2021/9989757. eCollection 2021.
5
Current practice in patients with differentiated thyroid cancer.分化型甲状腺癌患者的现行治疗方法。
Nat Rev Endocrinol. 2021 Mar;17(3):176-188. doi: 10.1038/s41574-020-00448-z. Epub 2020 Dec 18.
6
Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a single center retrospective study.临床病理因素及术前超声特征预测甲状腺微小乳头状癌中央区淋巴结转移:单中心回顾性研究。
Braz J Otorhinolaryngol. 2022 Jan-Feb;88(1):36-45. doi: 10.1016/j.bjorl.2020.05.004. Epub 2020 Jun 4.
7
Modern surgery for advanced thyroid cancer: a tailored approach.晚期甲状腺癌的现代外科治疗:一种个体化治疗方法。
Gland Surg. 2020 Feb;9(Suppl 2):S105-S119. doi: 10.21037/gs.2019.12.16.
8
The surgical management of locally advanced well-differentiated thyroid carcinoma: changes over the years according to the AJCC 8th edition Cancer Staging Manual.局部晚期高分化甲状腺癌的外科治疗:根据美国癌症联合委员会(AJCC)第8版癌症分期手册的多年变化情况
Thyroid Res. 2019 Oct 27;12:10. doi: 10.1186/s13044-019-0071-3. eCollection 2019.
9
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.甲状腺癌:ESMO 诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 Dec 1;30(12):1856-1883. doi: 10.1093/annonc/mdz400.
10
Evolving Understanding of the Epidemiology of Thyroid Cancer.甲状腺癌流行病学认识的演变。
Endocrinol Metab Clin North Am. 2019 Mar;48(1):23-35. doi: 10.1016/j.ecl.2018.10.002. Epub 2018 Dec 23.